Nifedipine controlled release tablet and preparation method thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- HYBIO PHARMA
- Publication Date
- 2022-07-01
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of pharmaceutical preparations, and relates to a nifedipine controlled-release tablet and a preparation method thereof. Background technique
[0002] Nifedipine is a dihydropyridine calcium channel antagonist. This product can dilate the coronary arteries in the normal blood supply area and ischemic area at the same time, antagonize spontaneous or ergometrine-induced coronary artery spasm, and increase myocardial oxygenation in patients with coronary artery spasm. Deliver, relieve and prevent coronary spasm; can inhibit myocardial contraction, reduce myocardial metabolism, reduce myocardial oxygen consumption; dilate peripheral resistance blood vessels, reduce peripheral resistance, reduce systolic and diastolic blood pressure, and reduce cardiac afterload. It is commonly used clinically for various types of angina pectoris (especially variant angina pectoris), hypertension, refractory congestive heart failure and oth...